Expanding Cancer Drug Horizons: New Targets Found
Researchers from Baylor College of Medicine, along with their partners, have identified promising new targets for cancer therapy and gained new insights into existing cancer drugs. By integrating data from proteomics, genomics, and epigenomics across 10 types of cancer, the team pinpointed protein and peptide targets in cancer tissues. Many of these targets were validated…